Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,873 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02623010 | Bruton's Tyrosine Kinase Inhibitor Ibrutinib as Maintenance Treatment in Elderly Patients With Primary CNS Lymphoma | unknown | Phase 2 | 30 | Rabin Medical CenterOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT00075387 | Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors | unknown | Phase 2 | 48 | OHSU Knight Cancer InstituteOTHER | 1 | May 3, 2022 | clinicaltrials |
| NCT05333588 | The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme. | unknown | Early Phase 1 | 20 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | Apr 19, 2022 | clinicaltrials |
| NCT05334238 | Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma | unknown | Phase 3 | 174 | Ruijin HospitalOTHER | 1 | Apr 19, 2022 | clinicaltrials |
| NCT02973256 | Oncological Care for Patients With Meningioma(ATYPICMENING) | unknown | — | 1,204 | University Hospital, MontpellierOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT04514393 | Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma | unknown | Phase 2 | 33 | Huiqiang HuangOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT05051488 | Dynamic Decompressive Craniotomy | unknown | — | 20 | Rohit Khanna, MDINDUSTRY | 0 | Apr 6, 2022 | clinicaltrials |
| NCT05308043 | Deep Learning in Retinoblastoma Detection and Monitoring. | unknown | — | 200 | Beijing Tongren HospitalOTHER | 1 | Apr 1, 2022 | clinicaltrials |
| NCT02013336 | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors | unknown | Phase 1 | 30 | South Plains Oncology ConsortiumNETWORK | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04738110 | Post-operative Imaging in High Grade Glioma: is Management Influenced?(PIGMI) | unknown | — | 150 | King's College Hospital NHS TrustOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05300113 | Artificial Intelligence Neuropathologist | unknown | — | 1,000 | Huashan HospitalOTHER | 1 | Mar 29, 2022 | clinicaltrials |
| NCT05287750 | Brain Diseases on 7.0T Magnetic Resonance Imaging | unknown | N/A | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT05202899 | Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy | unknown | Phase 4 | 40 | Guangzhou General Hospital of Guangzhou Military CommandOTHER | 1 | Mar 9, 2022 | clinicaltrials |
| NCT01951469 | Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer | unknown | Phase 3 | 160 | Sun Yat-sen UniversityOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT02313389 | Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma(BLOCAGE-01) | unknown | Phase 3 | 428 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04049864 | DNA Vaccination Against Neuroblastoma | unknown | Early Phase 1 | 12 | Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04967027 | Phase 1 Trial for Tumor Treating Field for Drug/Radiation Resistant Brain Metastases | unknown | Early Phase 1 | 5 | Xiangya Hospital of Central South UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04253496 | Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL)(LOC-MODEL) | unknown | — | 100 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 18, 2022 | clinicaltrials |
| NCT05177185 | Hippocampal-Sparing Stereotactic Radiosurgery Treatment of Brain Metastases Using CyberKnife(HiSparCK) | unknown | Phase 2 | 70 | Ottawa Hospital Research InstituteOTHER | 0 | Feb 16, 2022 | clinicaltrials |
| NCT04890444 | China Adrenal Disease Registry(CASE) | unknown | — | 2,000 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Feb 14, 2022 | clinicaltrials |
| NCT05207904 | Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases | unknown | Phase 2 | 41 | Sun Yat-sen UniversityOTHER | 1 | Jan 26, 2022 | clinicaltrials |
| NCT04539431 | Glioma Brain Tumours - E12513 - SensiScreen Glioma | unknown | — | 220 | Ente Ospedaliero Cantonale, BellinzonaOTHER | 1 | Jan 24, 2022 | clinicaltrials |
| NCT02796261 | Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients(STELLAR) | unknown | Phase 3 | 343 | Orbus Therapeutics, Inc.INDUSTRY | 8 | Jan 21, 2022 | clinicaltrials |
| NCT05201326 | Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 21, 2022 | clinicaltrials |
| NCT05179850 | Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children | unknown | — | 400 | West China HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05199363 | Pediatric Patient Experience on a Diagnostic Path | unknown | N/A | 300 | Children's Memorial Health Institute, PolandOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05188534 | ZOOMit-fMRI Identifies Language Functional Cortex | unknown | — | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 12, 2022 | clinicaltrials |
| NCT05143775 | Strategic Intervention on Preserving Language Function During Awake Craniotomy | unknown | N/A | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT05167630 | Prognosis Factors in Patients With Primary Central Nervous System Lymphoma | unknown | — | 40 | Zhengzhou UniversityOTHER | 1 | Dec 22, 2021 | clinicaltrials |
| NCT05143788 | Strategic Intervention on Preserving Motor Function During Awake Craniotomy | unknown | N/A | 60 | Beijing Neurosurgical InstituteOTHER | 0 | Dec 20, 2021 | clinicaltrials |
| NCT03400917 | Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma | unknown | Phase 2 | 55 | Aivita Biomedical, Inc.INDUSTRY | 1 | Dec 16, 2021 | clinicaltrials |
| NCT05160818 | Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases(SATURNUS) | unknown | N/A | 126 | Technical University of MunichOTHER | 1 | Dec 16, 2021 | clinicaltrials |
| NCT04888611 | Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma | unknown | Phase 2 | 40 | Huashan HospitalOTHER | 1 | Nov 30, 2021 | clinicaltrials |
| NCT05131711 | Combination of Stereotactic Radiosurgery and Enhanced Immunotherapy for Recurrent Glioblastomas(inSituVac2)(CSREIG)(CSREIG) | unknown | Phase 1 / Phase 2 | 60 | Beijing Tiantan HospitalOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05131763 | NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors | unknown | Phase 1 | 3 | Fudan UniversityOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT05108012 | Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients | unknown | Phase 1 | 5 | Royan InstituteOTHER_GOV | 1 | Nov 22, 2021 | clinicaltrials |
| NCT05126875 | Re-TREAT: Re-irradiation for Relapsed Brain Metastases(RE-TREAT) | unknown | N/A | 44 | Rigshospitalet, DenmarkOTHER | 1 | Nov 19, 2021 | clinicaltrials |
| NCT05125666 | Efficacy of Dual Task Training on Children With Ataxia After Medulloblastoma Resection | unknown | Phase 2 | 30 | Cairo UniversityOTHER | 1 | Nov 18, 2021 | clinicaltrials |
| NCT05106179 | The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma | unknown | Phase 4 | 1,000 | Center for Vascular Pathology, MoscowOTHER | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00983398 | Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors | unknown | Phase 1 / Phase 2 | 17 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 26, 2021 | clinicaltrials |
| NCT02743429 | Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma | unknown | Phase 2 | 40 | University Medicine GreifswaldOTHER | 2 | Oct 4, 2021 | clinicaltrials |
| NCT05054426 | Intermediate Dose of IV MTX as CNS Prophylaxis for High Risk DLBCL(NHL-011) | unknown | Phase 3 | 488 | Peking Union Medical College HospitalOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT00293475 | Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma | unknown | Phase 1 / Phase 2 | 81 | OHSU Knight Cancer InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT03264300 | Development and Validation of Advanced MRI Methods for Clinical Applications | unknown | N/A | 220 | St. Joseph's Hospital and Medical Center, PhoenixOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT03582254 | Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 Years(LOCALYSE) | unknown | N/A | 62 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03932981 | First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression(TEMOTRAD01) | unknown | Phase 2 | 60 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT04407039 | Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning | unknown | — | 350 | Tao XinOTHER | 0 | Sep 9, 2021 | clinicaltrials |
| NCT03973450 | Epidemiology of Pituitary Tumours: Prevalence of Associated Neoplasia(EpidemioPIT) | unknown | — | 400 | Neuromed IRCCSOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04277403 | HA-WBRT vs SRS in Patients With Multiple Brain Metastases(HipSter) | unknown | Phase 3 | 150 | Medical University InnsbruckOTHER | 1 | Sep 5, 2021 | clinicaltrials |
Data updated 23 days agoSource updated May 10, 2022source: clinicaltrials